Activest Wealth Management
IONS icon

Activest Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Activest Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1
Closed -$79 – 1211
2026
Q2 		$79 Buy
+1
New +$75 ﹤0.01% 1266
2026
Q1 		– Sell
-32
Closed -$2.53K – 1282
2025
Q4 		$2.53K Buy
+32
New +$2.41K ﹤0.01% 855
2025
Q1 		– Sell
-1
Closed -$33 – 1118
2024
Q4 		$35 Buy
+1
New +$37 ﹤0.01% 794

Other funds holding IONS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Tweedy, Browne Co
Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return

Activest Wealth Management's IONS Position: Q3 2026 in Review

Activest Wealth Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 1 share — an estimated $79 sold.

Activest Wealth Management first reported a position in IONS in Q4 2024 and held it in 3 quarters. The position peaked at $2.53K in Q4 2025. 175 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Activest Wealth Management reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Activest Wealth Management sold 1 Ionis Pharmaceuticals share in Q3 2026, an estimated $79.
  • Activest Wealth Management first reported a position in Ionis Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Activest Wealth Management's Ionis Pharmaceuticals position peaked at $2.53K in Q4 2025.
  • 175 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.